Miller, Jeffrey C.
Sangamo Therapeutics, Inc.,
United States
2025 Rank: 225150
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biotechnology
SubField 2:
Developmental Biology
Rank in SubField 1: 1104 out of 66225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 225150 | 253042 |
| Total Cites | 719 | 742 |
| H-index | 16 | 16 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 126 | 130 |
| Number of Single+First+Last Authored Papers | 6 | 6 |
| Total Cites to Single+First+Last Authored Papers | 126 | 130 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 554 | 566 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.31 |
| Self-Citation Percentage |
3.10%
|
|
Miller, Jeffrey C.
Sangamo Therapeutics, Inc.,
United States
2024 Rank: 186700
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Developmental Biology
Rank in SubField 1: 892 out of 62673 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 186700 | 217633 |
| Total Cites | 745 | 761 |
| H-index | 17 | 17 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 132 | 132 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 132 | 132 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 584 | 594 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.28 |
| Self-Citation Percentage |
2.10%
|
|
Miller, Jeffrey C.
Sangamo Therapeutics, Inc.,
United States
2023 Rank: 164077
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Developmental Biology
Rank in SubField 1: 794 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 164077 | 192180 |
| Total Cites | 857 | 879 |
| H-index | 18 | 18 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 150 | 150 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 150 | 150 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 657 | 675 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.30 |
| Self-Citation Percentage |
2.50%
|
|
Miller, Jeffrey C.
Sangamo Therapeutics, Inc.,
United States
2022 Rank: 161513
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Developmental Biology
Rank in SubField 1: 742 out of 56174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 161513 | 193928 |
| Total Cites | 822 | 854 |
| H-index | 18 | 19 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 130 | 131 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 130 | 131 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 619 | 638 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.34 |
| Self-Citation Percentage |
3.75%
|
|
Miller, Jeffrey C.
Sangamo Therapeutics, Inc.,
United States
2021 Rank: 191450
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biotechnology
SubField 2:
Developmental Biology
Rank in SubField 1: 911 out of 52513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 191450 | 216934 |
| Total Cites | 1208 | 1262 |
| H-index | 19 | 20 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 206 | 208 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 206 | 208 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 899 | 934 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.35 |
| Self-Citation Percentage |
4.28%
|
|
Miller, Jeffrey C.
Sangamo Therapeutics, Inc.,
United States
2020 Rank: 148386
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biotechnology
SubField 2:
Developmental Biology
Rank in SubField 1: 683 out of 50343 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 148386 | 163045 |
| Total Cites | 1053 | 1121 |
| H-index | 18 | 19 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 178 | 186 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 178 | 186 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 778 | 813 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.38 |
| Self-Citation Percentage |
6.07%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.